0001708138-22-000014.txt : 20220216 0001708138-22-000014.hdr.sgml : 20220216 20220216161803 ACCESSION NUMBER: 0001708138-22-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220214 FILED AS OF DATE: 20220216 DATE AS OF CHANGE: 20220216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MURPHY ANDREW J CENTRAL INDEX KEY: 0001796226 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 22643788 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-02-14 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001796226 MURPHY ANDREW J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Research Common Stock 2022-02-14 4 M 0 10000 179.13 A 68470 D Common Stock 2022-02-14 4 F 0 6460 626.79 D 62010 D Common Stock 2022-02-15 4 S 0 99 622.09 D 61911 D Common Stock 2022-02-15 4 S 0 50 625.9 D 61861 D Common Stock 2022-02-15 4 S 0 421 626.51 D 61440 D Common Stock 2022-02-15 4 S 0 630 627.49 D 60810 D Common Stock 2022-02-15 4 S 0 520 628.62 D 60290 D Common Stock 2022-02-15 4 S 0 533 629.35 D 59757 D Common Stock 2022-02-15 4 S 0 434 630.41 D 59323 D Common Stock 2022-02-15 4 S 0 185 631.67 D 59138 D Common Stock 2022-02-15 4 S 0 289 632.71 D 58849 D Common Stock 2022-02-15 4 S 0 220 633.54 D 58629 D Common Stock 2022-02-15 4 S 0 159 634.43 D 58470 D Common Stock 4269 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 179.13 2022-02-14 4 M 0 10000 0.0 D 2022-12-14 Common Stock 10000 30000 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 99 shares of Company stock on February 15, 2022 at prices ranging from $622.00 to $622.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. Represents volume-weighted average price of sales of 421 shares of Company stock on February 15, 2022 at prices ranging from $626.08 to $626.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. Represents volume-weighted average price of sales of 630 shares of Company stock on February 15, 2022 at prices ranging from $627.00 to $627.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. Represents volume-weighted average price of sales of 520 shares of Company stock on February 15, 2022 at prices ranging from $628.09 to $628.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. Represents volume-weighted average price of sales of 533 shares of Company stock on February 15, 2022 at prices ranging from $629.00 to $629.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. Represents volume-weighted average price of sales of 434 shares of Company stock on February 15, 2022 at prices ranging from $630.18 to $630.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. Represents volume-weighted average price of sales of 185 shares of Company stock on February 15, 2022 at prices ranging from $631.29 to $631.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. Represents volume-weighted average price of sales of 289 shares of Company stock on February 15, 2022 at prices ranging from $632.28 to $632.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. Represents volume-weighted average price of sales of 220 shares of Company stock on February 15, 2022 at prices ranging from $633.26 to $633.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. Represents volume-weighted average price of sales of 159 shares of Company stock on February 15, 2022 at prices ranging from $634.23 to $634.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Andrew Murphy 2022-02-16